Table 2 Micro array analysis revealed alterations of gene activity by comparing physiological and diabetogenic conditions
5.5 m M vs 11 m M glucose | 5.5 m M vs 11 m M glucose+insulin | |
---|---|---|
Proliferation/cell cycle | ||
Cyclin A1 | 14.09 | 11.13 |
Cyclin E2 | 4.90 | 2.39 |
E2F transcription factor 3 | 4.16 | 4.80 |
Signal transduction | ||
Integrin-linked kinase | 3.92 | 4.85 |
Phosphoinositide-3-kinase | 2.76 | 4.05 |
Protein kinase Cα | 4.68 | 9.71 |
Protein kinase Cδ | 4.55 | 5.01 |
MLCK | 6.28 | 4.03 |
Cell migration and adhesion | ||
Integrin β1 | 5.10 | 3.71 |
Integrin α2 | 5.66 | 4.89 |
Myosin IA | 4.27 | 6.37 |
Myosin IE | 4.44 | 8.35 |
Myosin VIIA | 4.31 | 11.90 |
Nonmuscle myosin II | 3.75 | 4.07 |
N-cadherin (neuronal) | 3.79 | 6.35 |
VE-cadherin (vascular) | 2.90 | 5.76 |
Matrix metallopeptidase 7 | 3.41 | 3.55 |
Matrix metallopeptidase 10 | 2.94 | 2.26 |
TIMP metallopeptidase inhibitor 3 | 0.40 | 0.33 |
E-cadherin (epithelial) | 0.22 | 0.25 |